Citadel Advisors
CALC icon

Citadel Advisors’s CalciMedica CALC Stock Holding History

Citadel Advisors’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.83K Buy
+18,200
New +$36.9K ﹤0.01% 12763
2023
Q1 		– Sell
-2,536
Closed -$17.8K – 14759
2022
Q4 		$17.8K Sell
2,536
-1,150
-31% -$12.9K ﹤0.01% 13231
2022
Q3 		$49K Sell
3,686
-607
-14% -$8.59K ﹤0.01% 11643
2022
Q2 		$66K Buy
4,293
+2,357
+122% +$32.2K ﹤0.01% 11750
2022
Q1 		$33K Sell
1,936
-2,750
-59% -$52.4K ﹤0.01% 13049
2021
Q4 		$120K Sell
4,686
-1,928
-29% -$74.9K ﹤0.01% 12525
2021
Q3 		$307K Sell
6,614
-3,322
-33% -$187K ﹤0.01% 11031
2021
Q2 		$755K Buy
+9,936
New +$652K ﹤0.01% 9086

Other funds holding CALC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors's CALC Position: Q2 2022 in Review

Citadel Advisors sold out of CalciMedica (CALC) in Q2 2022, closing a stake of 3,686 shares — an estimated $50.3K sold.

Citadel Advisors first reported a position in CALC in Q3 2020 and held it in 4 quarters. The position peaked at $4.96M in Q3 2020. 25 funds tracked by Wall St. Rank hold CALC as of Q2 2022.

  • Citadel Advisors reported no remaining CalciMedica position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 3,686 CalciMedica shares in Q2 2022, an estimated $50.3K.
  • Citadel Advisors first reported a position in CalciMedica in Q3 2020 and held it in 4 quarters.
  • Citadel Advisors's CalciMedica position peaked at $4.96M in Q3 2020.
  • 25 funds tracked by Wall St. Rank held CalciMedica as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.